These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3030696)

  • 1. A putative mediator of insulin action which inhibits adenylate cyclase and adenosine 3',5'-monophosphate-dependent protein kinase: partial purification from rat liver: site and kinetic mechanism of action.
    Malchoff CD; Huang L; Gillespie N; Palasi CV; Schwartz CF; Cheng K; Hewlett EL; Larner J
    Endocrinology; 1987 Apr; 120(4):1327-37. PubMed ID: 3030696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of streptozotocin-induced diabetes on adenylate cyclase activity in cultured type II pneumocytes.
    Brown LA
    Am J Respir Cell Mol Biol; 1991 Feb; 4(2):108-14. PubMed ID: 1846745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and a putative insulin metabolic mediator fraction from liver and muscle stimulate p33 messenger ribonucleic acid accumulation by apparently different mechanisms.
    Sato T; Palasi CV; Huang L; Tang G; Larner AC; Larner J
    Endocrinology; 1988 Sep; 123(3):1559-64. PubMed ID: 3042371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and partial characterization of a putative mediator of insulin action on cyclic AMP-dependent protein kinase.
    Thompson MP; Larner J; Kilpatrick DL
    Mol Cell Biochem; 1984 Apr; 62(1):67-75. PubMed ID: 6377044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells.
    de Mazancourt P; Lacasa D; Giot J; Giudicelli Y
    Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanine nucleotide binding regulatory proteins and adenylate cyclase in livers of streptozotocin- and BB/Wor-diabetic rats. Immunodetection of Gs and Gi with antisera prepared against synthetic peptides.
    Lynch CJ; Blackmore PF; Johnson EH; Wange RL; Krone PK; Exton JH
    J Clin Invest; 1989 Jun; 83(6):2050-62. PubMed ID: 2498395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of insulin mediators in regulation of cAMP and lipogenesis as well as in diabetes.
    Zhang SR; Wei TQ; Yao WZ; Han JH; Xing XQ; Wang Y; Wang JZ; Yue Y
    Sci Sin B; 1987 Aug; 30(8):832-41. PubMed ID: 2830665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin stimulation of cyclic AMP phosphodiesterase is independent from the G-protein pathways involved in adenylate cyclase regulation.
    Weber HW; Chung FZ; Day K; Appleman MM
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):345-54. PubMed ID: 3040818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic AMP, adenylate cyclase and cyclic AMP-phosphodiesterase activities in diabetic rat adipocytes.
    Chiappe de Cingolani GE
    Acta Physiol Pharmacol Latinoam; 1986; 36(1):39-46. PubMed ID: 3020875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin inhibits corticotropin-releasing factor-stimulated adrenocorticotropin release, adenylate cyclase, and activation of adenosine 3',5'-monophosphate-dependent protein kinase isoenzymes in AtT20 cells.
    Litvin Y; Leiser M; Fleischer N; Erlichman J
    Endocrinology; 1986 Aug; 119(2):737-45. PubMed ID: 2426087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of streptozotocin-diabetic rats with metformin restores the ability of insulin to inhibit adenylate cyclase activity and demonstrates that insulin does not exert this action through the inhibitory guanine nucleotide regulatory protein Gi.
    Gawler D; Milligan G; Houslay MD
    Biochem J; 1988 Jan; 249(2):537-42. PubMed ID: 3124829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats.
    Soman V; Felig P
    J Clin Invest; 1978 Mar; 61(3):552-60. PubMed ID: 205552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue levels, source, and regulation of 3'-AMP: an intracellular inhibitor of adenylyl cyclases.
    Bushfield M; Shoshani I; Johnson RA
    Mol Pharmacol; 1990 Dec; 38(6):848-53. PubMed ID: 2174505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic AMP-lowering mediator of insulin.
    Zhang SR; Shi QH; Ho RJ
    J Biol Chem; 1983 May; 258(10):6471-6. PubMed ID: 6304042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lowered responsiveness of the catalyst of adenylyl cyclase to stimulation by GS in heterologous desensitization: a role for adenosine 3',5'-monophosphate-dependent phosphorylation.
    Premont RT; Jacobowitz O; Iyengar R
    Endocrinology; 1992 Dec; 131(6):2774-84. PubMed ID: 1332848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-Mn2+ stimulates the generation of a putative mediator of insulin action.
    Suzuki S; Toyota T; Tamura S; Kikuchi K; Tsuiki S; Huang L; Villar-Palasi C; Larner J; Goto Y
    J Biol Chem; 1987 Mar; 262(7):3199-204. PubMed ID: 3546303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative adenylate cyclase activities in homogenate and plasma membrane fractions of Morris hepatoma 5123tc (h).
    Hickie RA; Jan SH; Datta A
    Cancer Res; 1975 Mar; 35(3):596-600. PubMed ID: 163685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways.
    Zhang LB; Buxton IL
    Mol Pharmacol; 1991 Dec; 40(6):952-9. PubMed ID: 1661840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early alterations of Gi/Go protein-dependent transductional processes in the retina of diabetic animals.
    Abbracchio MP; Cattabeni F; Di Giulio AM; Finco C; Paoletti AM; Tenconi B; Gorio A
    J Neurosci Res; 1991 Jun; 29(2):196-200. PubMed ID: 1653857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antilipolytic effects of insulin and adenylate cyclase inhibitors on isolated human fat cells.
    Lönnqvist F; Wennlund A; Arner P
    Int J Obes; 1989; 13(2):137-46. PubMed ID: 2545639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.